KCM
LEGN icon

Kynam Capital Management’s Legend Biotech LEGN Stock Holding History

Kynam Capital Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$86.7M Buy
3,001,205
+1,424,910
+90% +$38.4M 4.79% 10
2026
Q1 		$28.5M Buy
+1,576,295
New +$30.1M 1.76% 15
2025
Q2 		– Sell
-610,000
Closed -$20.7M – 32
2025
Q1 		$20.7M Buy
+610,000
New +$21.9M 1.74% 18

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Kynam Capital Management's LEGN Position: Q2 2026 in Review

Kynam Capital Management increased its Legend Biotech (LEGN) stake by 90% in Q2 2026, buying an estimated $38.4M and bringing the position to 3,001,205 shares worth $86.7M. The position accounts for 4.79% of the portfolio, ranked #10.

Kynam Capital Management first reported a position in LEGN in Q1 2025 and has held it in 3 quarters since. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Kynam Capital Management held 3,001,205 shares of Legend Biotech worth $86.7M as of Q2 2026.
  • Kynam Capital Management bought 1,424,910 Legend Biotech shares in Q2 2026, an estimated $38.4M.
  • Legend Biotech made up 4.79% of Kynam Capital Management's portfolio in Q2 2026, its #10 holding.
  • Kynam Capital Management first reported a position in Legend Biotech in Q1 2025 and has held it in 3 quarters since.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Kynam Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.